Igfbp2 biomarker

G - Physics – 01 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

G01N 33/574 (2006.01)

Patent

CA 2655997

The present invention provides method for quickly and conveniently determining if a given treatment regimen of IGF1R inhibitor is sufficient, e.g., to saturate IGF1 R receptors in the body of a subject. Several clinically relevant determinations may be made based on this point, including, for example, whether the dosage of the regimen is sufficient or should be increased.

La présente invention concerne un procédé qui permet de déterminer rapidement et commodément si un régime donné de traitement par un inhibiteur des IGF1R est suffisant, par exemple pour saturer les récepteurs IGF1R dans l'organisme d'un sujet. Selon l'invention, ceci permet de faire plusieurs déterminations cliniquement pertinentes, permettant par exemple de décider si la dose du régime est suffisante ou si elle doit être augmentée.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Igfbp2 biomarker does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Igfbp2 biomarker, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Igfbp2 biomarker will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1414172

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.